Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
- Conditions
- StrokeAphasia Following Cerebral InfarctionHemiparesis After Stroke
- Registration Number
- NCT07000019
- Lead Sponsor
- New York Medical College
- Brief Summary
The goal of this clinical trial is to learn if a program that combines language and arm treatment can improve language and movement problems in people with chronic stroke. The mains questions it aims to answer are:
* To determine the extent to which this combined treatment can improve language.
* To determine the extent to which the combined treatment can improve arm movements.
Researchers will compare the effects of this combined treatment with treatment that targets arm movements alone.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 28
- Male or female patients between 18-90 years of age.
- Right-handed prior to stroke
- English-speaking (monolingual)
- History of single left-hemisphere stroke at least 6 months prior to enrollment
- Presence of aphasia and naming deficits on Western Aphasia Battery (WAB-R)
- Comprehension score above 4 on WAB-R
- Unilateral upper limb paresis (Fugl-Meyer Upper Extremity score <56)
- Documentation of signed Informed Consent by the study participant.
- Diagnosis or history of speech impairment prior to stroke
- Severely limited speech output (score below 2 on spontaneous speech portion of WAB-R)
- Inability to perform screening tasks due to severe language and/or cognitive impairment
- Condition limiting passive movement in the range of motion required for robotic therapy (e.g. fixed contracture)
- Any medical or psychiatric condition that may impact participation or compliance with study procedures or activities in the opinion of the investigator
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Philadelphia Naming Test Baseline to 1 week post-treatment Fugl-Meyer Upper Extremity Motor Assessment Baseline to 1 week post-treatment
- Secondary Outcome Measures
Name Time Method Box and Blocks Test Baseline to 1 and 4 weeks post-training Apraxia Battery for Adults Baseline to 1 and 4 weeks post-training Western Aphasia Battery-Revised Aphasia Quotient Baseline to 4 weeks post-treatment Stroke and Aphasia Quality of Life Scale-39 Baseline to 1 and 4 weeks post-training Apraxia of Speech Rating Scale Baseline to 1 and 4 weeks post-training
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Westchester Medical Center / New York Medical College
🇺🇸Valhalla, New York, United States
Westchester Medical Center / New York Medical College🇺🇸Valhalla, New York, United StatesCristina Falo, PhDContactcristina.falo@wmchealth.orgTomoko Kitago, MDPrincipal Investigator